Screener
UroGen Pharma URGN Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts receivable, net | 88,757 | 33,082 |
| Inventories | 24,589 | 16,464 |
| Prepaid expenses and other current assets | 12,776 | 14,672 |
| Total current assets | 235,426 | 186,024 |
| Non-current assets: | ||
| Property and equipment, net | 597 | 637 |
| Restricted deposit | 178 | 177 |
| Finance lease right-of-use assets | 4,818 | 5,376 |
Item 1. Financial Statements.
FAQ
- What is UroGen Pharma's total current assets?
- UroGen Pharma (URGN) reported total current assets of $235.43M in Q2 2026.
- How has UroGen Pharma's total current assets changed year-over-year?
- UroGen Pharma's total current assets increased by 19.6% year-over-year, from $196.87M to $235.43M.
- What is the long-term trend for UroGen Pharma's total current assets?
- Over 5 years (2020 to 2025), UroGen Pharma's total current assets has grown at a 10.0% compound annual growth rate (CAGR), from $115.62M to $186.02M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about UroGen Pharma's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude